Page results
-
Information about sickle cell disorder in adulthood for UCLH patients.
-
The aim of this page is to give information about how we induce labours.
-
UCLH needs to reduce the amount we consume per patient, re-use and re-manufacture what we can and ensure that what we do use has minimal environmental impact. We also need to ensure our suppliers match our environmental ambitions. This page explores our progress so far.
-
Information about Magnetic Resonance Imaging (MRI) scans at UCLH.
-
Our Proton Beam Therapy (PBT) department can treat up to 650 NHS patients per year from across the south of the UK when we are at full capacity. We provide treatment for a wide range of child and teenage cancers and complex adult cancers.
-
The specialist allergy and clinical immunology service deals with the diagnosis and management of allergies and related immune system disorders in adults.
-
This information is about penile cancer multidisciplinary team (MDT), the a team of professionals who will be caring for you at University College Hospital (UCLH).
-
The snoring and sleep disorders clinic offers, out-patient consultation including flexible endoscopy to assess upper airway collapse. Multidisciplinary team involvement for planning treatment.
-
This page provides general information about care of wounds following spinal surgery.
-
UCLH patient information for using Control IQ technology
File results
-
FOI/2022/0169 - Strategic workforce plan for recruitment and retention of Allied Health Professions
-
FOI/2022/0171 - Consultant-led Referral to Treatment (RTT), outpatients and Patient Initiated Follow-up (PIFU)
-
FOI/2022/0172 - Contraceptive pill data
-
FOI/2022/0174 - Clinical systems for bed management, diagnostic reporting, discharge letters, and integration platform systems
-
FOI/2022/0177 - Assessment and treatment unit for mental health and learning disabilities
-
FOI/2022/0186 - Gender neutral toilets at the Trust
-
FOI/2022/0187 - Intra-operative cell salvage procedures
-
FOI/2022/0189 - Drug treatments for Revolade, Nplate, Doptelet, and Tavlesse
-
FOI/2022/0190 - Spend on private healthcare providers for staff
-
FOI/2022/0192 - Drug treatment for Melanoma patients